Indication

Hypercortisolism

Hypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids. Read more about Hypercortisolism

6 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Hypercortisolism therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Hypercortisolism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypercortisolism.

Hypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids.

It affects multiple organ systems and can arise from exogenous glucocorticoid administration or endogenous causes, which are further classified as ACTH-dependent (such as pituitary or ectopic ACTH-secreting tumors) or ACTH-independent (such as autonomous adrenal cortical adenomas or hyperplasia).

Pathophysiologically, the sustained excess of circulating cortisol disrupts metabolic, vascular, bone, and immune homeostasis.

Clinically, it manifests as central adiposity, facial plethora, proximal muscle weakness, purple cutaneous striae, osteoporosis, hypertension, and glucose intolerance.

Personalize your experience

Follow Hypercortisolism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it